Ares Management had Piper Sandler start coverage with an Overweight rating and a $150 target, which is a positive signal for its shares and investor interest.
An analyst began coverage of Ares with an Overweight rating and a $150 price target. That singlefirm upgrade signals more investor interest and implies upside versus the $121.48 close. No company-specific negatives were reported in the story.
MGE Energy had B of A start coverage with a Neutral rating and $76 target, a stance that neither raises nor lowers how we read the company today.
Turn Therapeutics had Lucid Capital Markets begin coverage with a Buy rating and a $24 target, which signals stronger analyst support for the stock.
Quince Therapeutics had Rodman & Renshaw start coverage with a Buy rating and a $70 target, which increases analyst backing for the company.
Enterprise Financial had StoneX begin coverage with a Buy rating and a $70 target, which is a favorable signal for the bank's shares.
Follow Ares Management Corp (ARES) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ARES